Huaren Pharmaceutical Co., Ltd.

SZSE:300110 Stock Report

Market Cap: CN¥4.3b

Huaren Pharmaceutical Balance Sheet Health

Financial Health criteria checks 5/6

Huaren Pharmaceutical has a total shareholder equity of CN¥2.8B and total debt of CN¥986.7M, which brings its debt-to-equity ratio to 34.8%. Its total assets and total liabilities are CN¥4.9B and CN¥2.0B respectively. Huaren Pharmaceutical's EBIT is CN¥305.8M making its interest coverage ratio 5.9. It has cash and short-term investments of CN¥120.1M.

Key information

34.8%

Debt to equity ratio

CN¥986.74m

Debt

Interest coverage ratio5.9x
CashCN¥120.10m
EquityCN¥2.84b
Total liabilitiesCN¥2.04b
Total assetsCN¥4.87b

Recent financial health updates

No updates

Recent updates

Some Investors May Be Willing To Look Past Huaren Pharmaceutical's (SZSE:300110) Soft Earnings

Nov 04
Some Investors May Be Willing To Look Past Huaren Pharmaceutical's (SZSE:300110) Soft Earnings

There Is A Reason Huaren Pharmaceutical Co., Ltd.'s (SZSE:300110) Price Is Undemanding

Oct 28
There Is A Reason Huaren Pharmaceutical Co., Ltd.'s (SZSE:300110) Price Is Undemanding

Huaren Pharmaceutical (SZSE:300110) Will Pay A Dividend Of CN¥0.021

Jul 05
Huaren Pharmaceutical (SZSE:300110) Will Pay A Dividend Of CN¥0.021

Financial Position Analysis

Short Term Liabilities: 300110's short term assets (CN¥2.5B) exceed its short term liabilities (CN¥1.4B).

Long Term Liabilities: 300110's short term assets (CN¥2.5B) exceed its long term liabilities (CN¥611.3M).


Debt to Equity History and Analysis

Debt Level: 300110's net debt to equity ratio (30.5%) is considered satisfactory.

Reducing Debt: 300110's debt to equity ratio has increased from 11.2% to 34.8% over the past 5 years.

Debt Coverage: 300110's debt is well covered by operating cash flow (39.9%).

Interest Coverage: 300110's interest payments on its debt are well covered by EBIT (5.9x coverage).


Balance Sheet


Discover healthy companies